MedPath

STARNOC

STARNOC

Discontinued
DIN Number

02297132

Drug Class

Human

Market Date

N/A

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02297132
AIG Number0140801002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05CF03 ZALEPLON
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ZALEPLONActive
Strength: 10 MG
Monograph: ZALEPLON

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.